Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach

被引:46
|
作者
Wang, Hong-Mei [1 ]
Huang, Chang-Ming [1 ]
Zheng, Chao-Hui [1 ]
Li, Ping [1 ]
Xie, Jian-Wei [1 ]
Wang, Jia-Bin [1 ]
Lin, Jian-Xian [1 ]
Lu, Jun [1 ]
机构
[1] Fujian Med Univ, Dept Gastr Surg, Affiliated Union Hosp, Fuzhou 350001, Fujian Province, Peoples R China
关键词
Gastric carcinoma; Prognosis; Receiver operating characteristic curve; The lower third of stomach; Tumor size; SEROSAL INVASION; INDICATOR; SURVIVAL; DIAMETER;
D O I
10.3748/wjg.v18.i38.5470
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To explore the impact of tumor size on outcomes in patients with advanced gastric cancer in the lower third of the stomach. METHODS: We retrospectively analyzed the clinical records of 430 patients with advanced gastric cancer in the lower third of the stomach who underwent distal subtotal gastrectomy and D2 lymphadenectomy in our hospital from January 1998 to June 2004. Receiver-operating characteristic (ROC) curve analysis was used to determine the appropriate cutoff value for tumor size, which was measured as maximum tumor diameter. Based on this cutoff value, patients were divided into two groups: those with large-sized tumors (LSTs) and those with small-sized tumors (SSTs). The correlations between other clinicopathologic factors and tumor size were investigated, and the 5-year overall survival (OS) rate was compared between the two groups. Potential prognostic factors were evaluated by univariate Kaplan-Meier survival analysis and multivariate Cox's proportional hazard model analysis. The 5-year OS rates in the two groups were compared according to pT stage and pN stage. RESULTS: The 5-year OS rate in the 430 patients with advanced gastric cancer in the lower third of the stomach was 53.7%. The mean +/- SD tumor size was 4.9 +/- 1.9 cm, and the median tumor size was 5.0 cm. ROC analysis indicated that the sensitivity and specificity results for the appropriate tumor size cutoff value of >= 4.8 cm were 80.0% and 68.2%, respectively (AUC = 0.795, 95%CI: 0.751-0.839, P = 0.000). Using this cutoff value, 222 patients (51.6%) had LSTs (tumor size 4.8 cm) and 208 (48.4%) had SSTs (tumor size < 4.8 cm). Tumor size was significantly correlated with histological type (P = 0.039), Borrmann type (P = 0.000), depth of tumor invasion (P = 0.000), lymph node metastasis (P = 0.000), tumor-nodes metastasis stage (P = 0.000), mean number of metastatic lymph nodes (P = 0.000) and metastatic lymph node ratio (P = 0.000). Patients with LSTs had a significantly lower 5-year OS rate than those with SSTs (37.1% vs 63.3%, P = 0.000). Univariate analysis showed that depth of tumor invasion (chi(2) = 69.581, P = 0.000), lymph node metastasis (chi(2) = 138.815, P = 0.000), tumor size (chi(2) = 78.184, P = 0.000) and metastatic lymph node ratio (chi(2) = 139.034, P = 0.000) were significantly associated with 5-year OS rate. Multivariate analysis revealed that depth of tumor invasion (P = 0.000), lymph node metastasis (P = 0.019) and tumor size (P = 0.000) were independent prognostic factors. Gastric cancers were divided into 12 subgroups: pT2N0; pT2N1; pT2N2; pT2N3; pT3N0; pT3N1; pT3N2; pT3N3; pT4aN0; pT4aN1; pT4aN2; and pT4aN3. In patients with pT2-3N3 stage tumors and patients with pT4a stage tumors, 5-year OS rates were significantly lower for LSTs than for SSTs (P < 0.05 each), but there were no significant differences in the 5-year OS rates in LST and SST patients with pT23N02 stage tumors (P > 0.05). CONCLUSION: Using a tumor size cutoff value of 4.8 cm, tumor size is a prognostic factor in patients with pN3 stage or pT4a stage advanced gastric cancer located in the lower third of the stomach. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:5470 / 5475
页数:6
相关论文
共 50 条
  • [1] Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach
    Hong-Mei Wang
    Zheng CH
    Wang JB
    and all authors read and approved the final manuscript.
    World Journal of Gastroenterology, 2012, (38) : 5470 - 5475
  • [2] Tumor Size as a Prognostic Factor in Gastric Cancer Patient
    Im, Won Jin
    Kim, Min Gyu
    Ha, Tae Kyung
    Kwon, Sung Joon
    JOURNAL OF GASTRIC CANCER, 2012, 12 (03) : 164 - 172
  • [3] Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer
    Shim, Hyun Jeong
    Yun, Ju Young
    Hwang, Jun Eul
    Bae, Woo Kyun
    Cho, Sang Hee
    Chung, Ik Joo
    GASTRIC CANCER, 2011, 14 (03) : 249 - 256
  • [4] Prognostic factor for third-line chemotherapy in patients with advanced gastric cancer.
    Choi, Jonggwon
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer
    Hyun Jeong Shim
    Ju Young Yun
    Jun Eul Hwang
    Woo Kyun Bae
    Sang Hee Cho
    Ik Joo Chung
    Gastric Cancer, 2011, 14 : 249 - 256
  • [6] Prognostic Significance of Lymph Node Dissection Along the Upper-third-stomach in Patients With Lower-third Gastric Cancer
    Saito, Ryo
    Kawaguchi, Yoshihiko
    Akaike, Hidenori
    Shiraishi, Kensuke
    Maruyama, Suguru
    Shimizu, Hiroki
    Furuya, Shinji
    Hosomura, Naohiro
    Amemiya, Hidetake
    Kawaida, Hiromichi
    Sudo, Makoto
    Inoue, Shingo
    Kono, Hiroshi
    Ichikawa, Daisuke
    ANTICANCER RESEARCH, 2019, 39 (03) : 1485 - 1489
  • [7] The prognostic role of tumor size in patients with gastric cancer
    Del Rio, Paolo
    Viani, Lorenzo
    Bertocchi, Elisa
    Iapichino, Gioacchino
    Luzietti, Enrico
    Dell'Abate, Paolo
    Sianesi, Mario
    ANNALI ITALIANI DI CHIRURGIA, 2017, 88 (06) : 478 - 484
  • [8] Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer.
    Yang, D. H.
    Bae, W. K.
    Hwang, J.
    Yoon, J.
    Chung, I.
    Shim, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer
    Yazici, Ozan
    Dogan, Mutlu
    Ozal, Guze
    Aktas, Sedef Hande
    Demirkazik, Ahmet
    Utkan, Gungor
    Senler, Filiz Cay
    Icli, Fikri
    Akbulut, Hakan
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2021, 24 (08) : 1229 - 1235
  • [10] Tumor diameter as a prognostic factor in patients with gastric cancer
    Kunisaki, Chikara
    Makino, Hirochika
    Takagawa, Ryo
    Oshima, Takashi
    Nagano, Yasuhiko
    Kosaka, Takashi
    Ono, Hidetaka A.
    Otsuka, Yuichi
    Akiyama, Hirotoshi
    Ichikawa, Yasushi
    Shimada, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (07) : 1959 - 1967